Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro
Keith Dredge(St George's, University of London), Rebecca Horsfall(St George's, University of London), Simon P. Robinson(St George's Hospital), Linghua Zhang, Ling Lu, Yang Tang, Michael A. Shirley, George W. Muller, Peter Schäfer, David Stirling, Angus Dalgleish(St George's Hospital), J. Blake Bartlett(St George's Hospital)
Cited by 268
Abstract
Related Papers
No related papers found
Powered by citation graph analysis